These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

176 related articles for article (PubMed ID: 32022261)

  • 1. A randomized, phase 1, placebo-controlled trial of APG-157 in oral cancer demonstrates systemic absorption and an inhibitory effect on cytokines and tumor-associated microbes.
    Basak SK; Bera A; Yoon AJ; Morselli M; Jeong C; Tosevska A; Dong TS; Eklund M; Russ E; Nasser H; Lagishetty V; Guo R; Sajed D; Mudgal S; Mehta P; Avila L; Srivastava M; Faull K; Jacobs J; Pellegrini M; Shin DS; Srivatsan ES; Wang MB
    Cancer; 2020 Apr; 126(8):1668-1682. PubMed ID: 32022261
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Curcumin treatment suppresses IKKβ kinase activity of salivary cells of patients with head and neck cancer: a pilot study.
    Kim SG; Veena MS; Basak SK; Han E; Tajima T; Gjertson DW; Starr J; Eidelman O; Pollard HB; Srivastava M; Srivatsan ES; Wang MB
    Clin Cancer Res; 2011 Sep; 17(18):5953-61. PubMed ID: 21821700
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nutraceuticals as new treatment approaches for oral cancer--I: Curcumin.
    Zlotogorski A; Dayan A; Dayan D; Chaushu G; Salo T; Vered M
    Oral Oncol; 2013 Mar; 49(3):187-91. PubMed ID: 23116961
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Curcumin and analogues against head and neck cancer: From drug delivery to molecular mechanisms.
    Zhao C; Zhou X; Cao Z; Ye L; Cao Y; Pan J
    Phytomedicine; 2023 Oct; 119():154986. PubMed ID: 37506572
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Curcumin gum formulation for prevention of oral cavity head and neck squamous cell carcinoma.
    Boven L; Holmes SP; Latimer B; McMartin K; Ma X; Moore-Medlin T; Khandelwal AR; McLarty J; Nathan CO
    Laryngoscope; 2019 Jul; 129(7):1597-1603. PubMed ID: 30421467
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Phase II trial of curcumin in patients with advanced pancreatic cancer.
    Dhillon N; Aggarwal BB; Newman RA; Wolff RA; Kunnumakkara AB; Abbruzzese JL; Ng CS; Badmaev V; Kurzrock R
    Clin Cancer Res; 2008 Jul; 14(14):4491-9. PubMed ID: 18628464
    [TBL] [Abstract][Full Text] [Related]  

  • 7. A Randomized Double-Blind Placebo-Controlled Phase IIB Trial of Curcumin in Oral Leukoplakia.
    Kuriakose MA; Ramdas K; Dey B; Iyer S; Rajan G; Elango KK; Suresh A; Ravindran D; Kumar RR; R P; Ramachandran S; Kumar NA; Thomas G; Somanathan T; Ravindran HK; Ranganathan K; Katakam SB; Parashuram S; Jayaprakash V; Pillai MR
    Cancer Prev Res (Phila); 2016 Aug; 9(8):683-91. PubMed ID: 27267893
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Possible action mechanism for curcumin in pre-cancerous lesions based on serum and salivary markers of oxidative stress.
    Rai B; Kaur J; Jacobs R; Singh J
    J Oral Sci; 2010 Jun; 52(2):251-6. PubMed ID: 20587949
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Curcumin inhibits glyoxalase 1: a possible link to its anti-inflammatory and anti-tumor activity.
    Santel T; Pflug G; Hemdan NY; Schäfer A; Hollenbach M; Buchold M; Hintersdorf A; Lindner I; Otto A; Bigl M; Oerlecke I; Hutschenreuther A; Sack U; Huse K; Groth M; Birkemeyer C; Schellenberger W; Gebhardt R; Platzer M; Weiss T; Vijayalakshmi MA; Krüger M; Birkenmeier G
    PLoS One; 2008; 3(10):e3508. PubMed ID: 18946510
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Cell-Free RNA as a Novel Biomarker for Response to Therapy in Head & Neck Cancer.
    Tosevska A; Morselli M; Basak SK; Avila L; Mehta P; Wang MB; Srivatsan ES; Pellegrini M
    Front Oncol; 2022; 12():869108. PubMed ID: 35600369
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Copper supplementation amplifies the anti-tumor effect of curcumin in oral cancer cells.
    Lee HM; Patel V; Shyur LF; Lee WL
    Phytomedicine; 2016 Nov; 23(12):1535-1544. PubMed ID: 27765374
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Combination nonviral interleukin-2 gene immunotherapy for head and neck cancer: from bench top to bedside.
    O'Malley BW; Li D; McQuone SJ; Ralston R
    Laryngoscope; 2005 Mar; 115(3):391-404. PubMed ID: 15744147
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of Salivary Microbiota and Its Association With Host Inflammatory Mediators in Periodontitis.
    Lundmark A; Hu YOO; Huss M; Johannsen G; Andersson AF; Yucel-Lindberg T
    Front Cell Infect Microbiol; 2019; 9():216. PubMed ID: 31281801
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cytokines in saliva as biomarkers of oral and systemic oncological or infectious diseases: A systematic review.
    Diesch T; Filippi C; Fritschi N; Filippi A; Ritz N
    Cytokine; 2021 Jul; 143():155506. PubMed ID: 33846070
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Curcumin: the story so far.
    Sharma RA; Gescher AJ; Steward WP
    Eur J Cancer; 2005 Sep; 41(13):1955-68. PubMed ID: 16081279
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Adjuvant therapy with bioavailability-boosted curcuminoids suppresses systemic inflammation and improves quality of life in patients with solid tumors: a randomized double-blind placebo-controlled trial.
    Panahi Y; Saadat A; Beiraghdar F; Sahebkar A
    Phytother Res; 2014 Oct; 28(10):1461-7. PubMed ID: 24648302
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Safety and pharmacokinetics of NXN-188 after single and multiple doses in five phase I, randomized, double-blind, parallel studies in healthy adult volunteers.
    Vaughan D; Speed J; Medve R; Andrews JS
    Clin Ther; 2010 Jan; 32(1):146-60. PubMed ID: 20171420
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Curcumin Modulates Glycolytic Metabolism and Inflammatory Cytokines via Nrf 2 in Dalton's Lymphoma Ascites Cells In Vivo.
    Das L; Vinayak M
    Anticancer Agents Med Chem; 2018; 18(12):1779-1791. PubMed ID: 29866021
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Curcumin in Combination With Mesalamine Induces Remission in Patients With Mild-to-Moderate Ulcerative Colitis in a Randomized Controlled Trial.
    Lang A; Salomon N; Wu JC; Kopylov U; Lahat A; Har-Noy O; Ching JY; Cheong PK; Avidan B; Gamus D; Kaimakliotis I; Eliakim R; Ng SC; Ben-Horin S
    Clin Gastroenterol Hepatol; 2015 Aug; 13(8):1444-9.e1. PubMed ID: 25724700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Curcumin: a Polyphenol with Molecular Targets for Cancer Control.
    Qadir MI; Naqvi ST; Muhammad SA
    Asian Pac J Cancer Prev; 2016; 17(6):2735-9. PubMed ID: 27356682
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.